Details of the Drug
General Information of Drug (ID: DMIOQFU)
| Drug Name |
Nitrilotriacetic Acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
NITRILOTRIACETIC ACID; 139-13-9; 2,2',2''-nitrilotriacetic acid; Triglycollamic acid; Aminotriacetic acid; Nitrilotriacetate; Complexon I; Trilon A; N,N-Bis(carboxymethyl)glycine; Titriplex I; Komplexon I; NTA; Versene NTA acid; Nitrilotriessigsaeure; Hampshire NTA acid; Nitriloacetate; 2-[bis(carboxymethyl)amino]acetic acid; Glycine, N,N-bis(carboxymethyl)-; Tri(carboxymethyl)amine; Tris(carboxymethyl)amine; Acetic acid, nitrilotri-; CHEL 300; NCI-C02766; Nitrilo-2,2',2''-triacetic acid; Nitrilotriacetic acid (NTA); CCRIS 436
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 191.14 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -3.2 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


